Titre : | Behavioral naltrexone therapy: an integrated treatment for opiate dependance |
Titre traduit : | (Thérapie comportementale à la naltrexone : un traitement intégré pour la dépendance aux opiacés) |
Auteurs : | J. L. ROTHENBERG ; M. A. SULLIVAN ; S. H. CHURCH ; A. SERACINI ; E. COLLINS ; H. D. KLEBER ; E. V. NUNES |
Type de document : | Périodique |
Année de publication : | 2002 |
Format : | 351-360 / graph. ; tabl. |
Note générale : |
Journal of Substance Abuse Treatment, 2002, 23, (4), 351-360 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés DEPENDANCE ; OPIACES ; THERAPIE COMPORTEMENTALE ; NALTREXONE |
Résumé : |
ENGLISH : Treatment of opiate dependence with naltrexone has been limited by poor compliance. Behavioral Naltrexone Therapy (BNT) was developed to promote adherence to naltrexone and lifestyle changes supportive of abstinence, by incorporating components from empirically validated treatments, including Network Therapy with a significant other to monitor medication compliance, the Community Reinforcement Approach, and voucher incentives. An overview is presented of the BNT treatment manual. In an uncontrolled Stage I trial (N= 47), 19% completed the 6-month course of treatment. Retention was especially poor in the subsample of patients who were using methadone at baseline (N= 18; 39% completed 1 month, none completed 6 months), and more encouraging among heroin-dependent patients (N= 29; 65% completed I month, 31 % completed 6 months). Thus, attrition continues to be a serious problem for naltrexone maintenance, although further efforts to develop interventions such as BNT are warranted. (Editor's abstract.) |
Note de contenu : | graph. ; tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 47 |
Affiliation : |
New York State Psychiatric Inst., Div. Substance Abuse, Substance Treatment Res. Service, 1051 Riverside Drive, New York, NY 10032. E-mail : rothenbpi.cpmc.columbia.edu Etats-Unis. United States. |
Numéro Toxibase : | 404035 |
Centre Emetteur : | 04 CIRDD-51 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil